TrialJACC. Heart failure2025

Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction.

Senthil Selvaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.